iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

NPPA sets price cap for 127 medicines, prices to fall

22 Dec 2022 , 07:22 AM

The National Pharmaceutical Pricing Authority (NPPA) on Tuesday set price caps for 127 medicines, making some drugs more affordable for a fifth time this year.

The cost of a number of medicines, including paracetamol, has decreased for the second time this year. But some medicines, including metformin and montelukast, have become more expensive.

The NPPA’s list of 127 drugs includes paracetamol, Amoxycillin, rabeprazole, and metformin. Many of these are frequently used by patients. Paracetamol (650 mg), which usually costs Rs2.3 a pill, is now only available for Rs1.8.

The NPPA decreased the cost of paracetamol combination formulation earlier this year. Amoxycillin and potassium clavulanate tablets’ cost also decreased from Rs22.3 to Rs16.8 per tablet.

Additionally, the cost of moxifloxacin (400mg) has been significantly reduced, going from Rs31.5 per tablet to Rs22.8 per tablet. This year saw the first decrease in price for the drug, which is used to treat bacterial infections including pneumonia.

The price of several prescriptions, such as metformin (500mg), was up from Rs1.7 to Rs1.8 as a result of the revised list. For the combination formulation of metformin, which is used to treat Type II diabetes, there have been a number of price modifications in the previous year.

Sajal Ganguly, secretary of the Bengal Chemists and Druggists Association (BCDA), asserts that by the end of January, medications with the new price tag would begin to arrive.

Related Tags

  • NPPA
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.